Year None20242023202220212020201920182017 Feb 05 / 24 Belite Bio Receives EMA Approval to Initiate Tinlarebant Phase 3 Clinical Trial for GA in France and Czech Republic Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 10 - 10 of 10
Feb 05 / 24 Belite Bio Receives EMA Approval to Initiate Tinlarebant Phase 3 Clinical Trial for GA in France and Czech Republic